Articles By Marcus Johnson
-
GSK Halts Trial For Immunotherapy Cancer Treatment
4/3/2014
UK based drug producer GlaxoSmithKline has dealt with a variety of setbacks in its recent clinical trials.The latest setback is with its new immunotherapy cancer treatment, MAGE-A3.
-
Wisconsin's Upper Chamber Passes Bill On Cancer Drugs
4/3/2014
The state senate in the Wisconsin legislature passed a bill this past Tuesday that would make cancer treatments more affordable for those taking chemotherapy pills.
-
Researchers Develop Wearable Smart Patch For Administering Drugs
4/2/2014
South Korean researchers at Seoul National University are working to develop a wearable smart patch which will be able to detect diseases and administer drugs on its own.
-
Study Shows Sleeping Pills And Anti-Anxiety Drugs Increase Risk Of Death
4/1/2014
A new study conducted at the University of Warwick and published in BMJ has shown that several different anti-anxiety drugs or sleeping pills double the risk of mortality.
-
Ontario Regulator Seeks To Reform Doctor-Drug Industry Relationship
4/1/2014
The largest medical regulator in Canada, the Ontario College of Physicians and Surgeons, has proposed a new ethics policy that would restrict doctors from receiving gifts from pharmaceutical companies. This new policy is part of a larger movement to reform and re-establish industry-physician relationships, The National Post says.
-
Study Shows Diabetes Drug Does Not Prevent Heart Failure
4/1/2014
A new study performed on the diabetes drug metformin has shown that the drug does not help prevent heart failure in non-diabetics who've already had a heart attack.
-
Delhi High Court Bans Generic Medication Sorefenat
3/28/2014
The Delhi High Court has temporarily banned the export of Sorefenat, a generic kidney and liver cancer medication.
-
Internal Turmoil For Sun Pharma
3/28/2014
Sun Pharmaceutical Industries is facing internal strife. The Indian based company is seeing opposition from minority shareholders in its bid to re-elect two of its nominees as independent directors to Taro Pharmaceutical. Taro Pharmaceutical is a subsidiary of Sun Pharma based in Israel.
-
Specialised Therapeutics Australia To Increase Pancreatic Cancer Treatment Cost
3/28/2014
Specialised Therapeutics Australia could not come to an agreement with the Australian government on the price of Abraxane, a drug for pancreatic cancer.
-
Drug Companies Following US Regulators On Use In Livestock
3/28/2014
Twenty-five drug companies are voluntarily phasing out the use of antibiotics for the growth of livestock.